APO Research
Talk to an analyst

APO RESEARCH · REPORT

STD Tests

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global STD Tests Market Outlook and Growth Opportunities 2026

31 December 2025196 pages

Choose your research edition.

Industry ResearchSTD Tests Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal STD Tests Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal STD Tests Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal STD Tests Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal STD Tests Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global STD Tests market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for STD Tests is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for STD Tests is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for STD Tests is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the STD Tests market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the STD Tests market include Orasure, Hologic Inc., F. Hoffmann-La Roche, DiaSorin, Danaher Corporation, Cepheid Inc., Bio-Rad Laboratories, BioMerieux and Becton Dickinson and Company, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global STD Tests market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of STD Tests and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents STD Tests revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global STD Tests market.

STD Tests Segment by Company

Orasure

Hologic Inc.

F. Hoffmann-La Roche

DiaSorin

Danaher Corporation

Cepheid Inc.

Bio-Rad Laboratories

BioMerieux

Becton Dickinson and Company

Alere Inc.

Affymetrix

Abbott Laboratories

STD Tests Segment by Type

HIV Testing

Hepatitis C Testing

Trichomonas’s Testing

Gonorrhoea Testing

Syphilis Testing

Chlamydia Testing

STD Tests Segment by Application

Diagnostic Centres

Hospitals

Homecare

Others

STD Tests Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global STD Tests status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the STD Tests key companies, revenue, market share, and recent developments.

3. To split the STD Tests breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions STD Tests market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify STD Tests significant trends, drivers, influence factors in global and regions.

6. To analyze STD Tests competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global STD Tests market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of STD Tests and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of STD Tests.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global STD Tests industry.

Chapter 3: Detailed analysis of STD Tests company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of STD Tests in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of STD Tests in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. STD Tests Industry Trends Table 2. STD Tests Industry Drivers Table 3. STD Tests Industry Opportunities and Challenges Table 4. STD Tests Industry Restraints Table 5. Global STD Tests Revenue by Company (US$ Million) & (2021-2026) Table 6. Global STD Tests Revenue Share by Company (2021-2026) Table 7. Global STD Tests Company Ranking, (2024-2026) & (US$ Million) Table 8. Global STD Tests Key Company Manufacturing Base & Headquarters Table 9. Global STD Tests Company, Product Type & Application Table 10. Global STD Tests Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global STD Tests by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of HIV Testing Table 15. Significant Companies of Hepatitis C Testing Table 16. Significant Companies of Trichomonas’s Testing Table 17. Significant Companies of Gonorrhoea Testing Table 18. Significant Companies of Syphilis Testing Table 19. Significant Companies of Chlamydia Testing Table 20. Global STD Tests Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 21. Global STD Tests Sales Value by Type (2021-2026) & (US$ Million) Table 22. Global STD Tests Sales Value by Type (2027-2032) & (US$ Million) Table 23. Global STD Tests Sales Value Share by Type (2021-2026) Table 24. Global STD Tests Sales Value Share by Type (2027-2032) Table 25. Significant Companies of Diagnostic Centres Table 26. Significant Companies of Hospitals Table 27. Significant Companies of Homecare Table 28. Significant Companies of Others Table 29. Global STD Tests Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global STD Tests Sales Value by Application (2021-2026) & (US$ Million) Table 31. Global STD Tests Sales Value by Application (2027-2032) & (US$ Million) Table 32. Global STD Tests Sales Value Share by Application (2021-2026) Table 33. Global STD Tests Sales Value Share by Application (2027-2032) Table 34. Global STD Tests Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global STD Tests Sales Value by Region (2021-2026) & (US$ Million) Table 36. Global STD Tests Sales Value Share by Region (2021-2026) Table 37. Global STD Tests Sales Value by Region (2027-2032) & (US$ Million) Table 38. Global STD Tests Sales Value Share by Region (2027-2032) Table 39. Global STD Tests Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global STD Tests Sales Value by Country (2021-2026) & (US$ Million) Table 41. Global STD Tests Sales Value Market Share by Country (2021-2026) Table 42. Global STD Tests Sales Value by Country (2027-2032) & (US$ Million) Table 43. Global STD Tests Sales Value Market Share by Country (2027-2032) Table 44. Orasure Company Information Table 45. Orasure Business Overview Table 46. Orasure STD Tests Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Orasure STD Tests Product Portfolio Table 48. Orasure Recent Development Table 49. Hologic Inc. Company Information Table 50. Hologic Inc. Business Overview Table 51. Hologic Inc. STD Tests Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Hologic Inc. STD Tests Product Portfolio Table 53. Hologic Inc. Recent Development Table 54. F. Hoffmann-La Roche Company Information Table 55. F. Hoffmann-La Roche Business Overview Table 56. F. Hoffmann-La Roche STD Tests Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. F. Hoffmann-La Roche STD Tests Product Portfolio Table 58. F. Hoffmann-La Roche Recent Development Table 59. DiaSorin Company Information Table 60. DiaSorin Business Overview Table 61. DiaSorin STD Tests Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. DiaSorin STD Tests Product Portfolio Table 63. DiaSorin Recent Development Table 64. Danaher Corporation Company Information Table 65. Danaher Corporation Business Overview Table 66. Danaher Corporation STD Tests Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Danaher Corporation STD Tests Product Portfolio Table 68. Danaher Corporation Recent Development Table 69. Cepheid Inc. Company Information Table 70. Cepheid Inc. Business Overview Table 71. Cepheid Inc. STD Tests Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Cepheid Inc. STD Tests Product Portfolio Table 73. Cepheid Inc. Recent Development Table 74. Bio-Rad Laboratories Company Information Table 75. Bio-Rad Laboratories Business Overview Table 76. Bio-Rad Laboratories STD Tests Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Bio-Rad Laboratories STD Tests Product Portfolio Table 78. Bio-Rad Laboratories Recent Development Table 79. BioMerieux Company Information Table 80. BioMerieux Business Overview Table 81. BioMerieux STD Tests Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. BioMerieux STD Tests Product Portfolio Table 83. BioMerieux Recent Development Table 84. Becton Dickinson and Company Company Information Table 85. Becton Dickinson and Company Business Overview Table 86. Becton Dickinson and Company STD Tests Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Becton Dickinson and Company STD Tests Product Portfolio Table 88. Becton Dickinson and Company Recent Development Table 89. Alere Inc. Company Information Table 90. Alere Inc. Business Overview Table 91. Alere Inc. STD Tests Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Alere Inc. STD Tests Product Portfolio Table 93. Alere Inc. Recent Development Table 94. Affymetrix Company Information Table 95. Affymetrix Business Overview Table 96. Affymetrix STD Tests Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Affymetrix STD Tests Product Portfolio Table 98. Affymetrix Recent Development Table 99. Abbott Laboratories Company Information Table 100. Abbott Laboratories Business Overview Table 101. Abbott Laboratories STD Tests Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Abbott Laboratories STD Tests Product Portfolio Table 103. Abbott Laboratories Recent Development Table 104. Research Programs/Design for This Report Table 105. Authors List of This Report Table 106. Secondary Sources Table 107. Primary Sources List of Figures Figure 1. STD Tests Product Image Figure 2. Global STD Tests Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global STD Tests Market Size (2021-2032) & (US$ Million) Figure 4. Global STD Tests Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. HIV Testing Image Figure 8. Hepatitis C Testing Image Figure 9. Trichomonas’s Testing Image Figure 10. Gonorrhoea Testing Image Figure 11. Syphilis Testing Image Figure 12. Chlamydia Testing Image Figure 13. Global STD Tests Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 14. Global STD Tests Sales Value Share 2021 VS 2025 VS 2032 Figure 15. Global STD Tests Sales Value Share by Type (2021-2032) Figure 16. Diagnostic Centres Image Figure 17. Hospitals Image Figure 18. Homecare Image Figure 19. Others Image Figure 20. Global STD Tests Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global STD Tests Sales Value Share 2021 VS 2025 VS 2032 Figure 22. Global STD Tests Sales Value Share by Application (2021-2032) Figure 23. Global STD Tests Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 24. Global STD Tests Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 25. North America STD Tests Sales Value (2021-2032) & (US$ Million) Figure 26. North America STD Tests Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Europe STD Tests Sales Value (2021-2032) & (US$ Million) Figure 28. Europe STD Tests Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Asia-Pacific STD Tests Sales Value (2021-2032) & (US$ Million) Figure 30. Asia-Pacific STD Tests Sales Value Share by Country (%), 2025 VS 2032 Figure 31. South America STD Tests Sales Value (2021-2032) & (US$ Million) Figure 32. South America STD Tests Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Middle East & Africa STD Tests Sales Value (2021-2032) & (US$ Million) Figure 34. Middle East & Africa STD Tests Sales Value Share by Country (%), 2025 VS 2032 Figure 35. USA STD Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. USA STD Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. USA STD Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Canada STD Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Canada STD Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Canada STD Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Mexico STD Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Mexico STD Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Mexico STD Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Germany STD Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Germany STD Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Germany STD Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. France STD Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. France STD Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. France STD Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. U.K. STD Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. U.K. STD Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. U.K. STD Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Italy STD Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Italy STD Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Italy STD Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Spain STD Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Spain STD Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Spain STD Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Russia STD Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Russia STD Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Russia STD Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Netherlands STD Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Netherlands STD Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Netherlands STD Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Nordic Countries STD Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Nordic Countries STD Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Nordic Countries STD Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. China STD Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. China STD Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. China STD Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Japan STD Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Japan STD Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Japan STD Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. South Korea STD Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. South Korea STD Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. South Korea STD Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. India STD Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. India STD Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. India STD Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Australia STD Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Australia STD Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Australia STD Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Southeast Asia STD Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Southeast Asia STD Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Southeast Asia STD Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Brazil STD Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Brazil STD Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Brazil STD Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Argentina STD Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Argentina STD Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Argentina STD Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Chile STD Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Chile STD Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Chile STD Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Colombia STD Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Colombia STD Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Colombia STD Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Peru STD Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Peru STD Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Peru STD Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Saudi Arabia STD Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Saudi Arabia STD Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Saudi Arabia STD Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Israel STD Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Israel STD Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Israel STD Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. UAE STD Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. UAE STD Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. UAE STD Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Turkey STD Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Turkey STD Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Turkey STD Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Iran STD Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Iran STD Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Iran STD Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Egypt STD Tests Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Egypt STD Tests Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Egypt STD Tests Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Years Considered Figure 120. Research Process Figure 121. Key Executives Interviewed

Scope & coverage.

Types
  • HIV Testing
  • Hepatitis C Testing
  • Trichomonas’s Testing
  • Gonorrhoea Testing
  • Syphilis Testing
  • Chlamydia Testing
Applications
  • Diagnostic Centres
  • Hospitals
  • Homecare
  • Others
Companies covered
  • Orasure
  • Hologic Inc.
  • F. Hoffmann-La Roche
  • DiaSorin
  • Danaher Corporation
  • Cepheid Inc.
  • Bio-Rad Laboratories
  • BioMerieux
  • Becton Dickinson and Company
  • Alere Inc.
  • Affymetrix
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global STD Tests Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global STD Tests Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 STD Tests Market Dynamics
  1. 2.1 STD Tests Industry Trends
  2. 2.2 STD Tests Industry Drivers
  3. 2.3 STD Tests Industry Opportunities and Challenges
  4. 2.4 STD Tests Industry Restraints
3 STD Tests Market by Company
  1. 3.1 Global STD Tests Company Revenue Ranking in 2025
  2. 3.2 Global STD Tests Revenue by Company (2021-2026)
  3. 3.3 Global STD Tests Company Ranking (2024-2026)
  4. 3.4 Global STD Tests Company Manufacturing Base and Headquarters
  5. 3.5 Global STD Tests Company Product Type and Application
  6. 3.6 Global STD Tests Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global STD Tests Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 STD Tests Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 STD Tests Market by Type
  1. 4.1 STD Tests Type Introduction
  2. 4.1.1 HIV Testing
  3. 4.1.2 Hepatitis C Testing
  4. 4.1.3 Trichomonas’s Testing
  5. 4.1.4 Gonorrhoea Testing
  6. 4.1.5 Syphilis Testing
  7. 4.1.6 Chlamydia Testing
  8. 4.2 Global STD Tests Sales Value by Type
  9. 4.2.1 Global STD Tests Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global STD Tests Sales Value by Type (2021-2032)
  11. 4.2.3 Global STD Tests Sales Value Share by Type (2021-2032)
5 STD Tests Market by Application
  1. 5.1 STD Tests Application Introduction
  2. 5.1.1 Diagnostic Centres
  3. 5.1.2 Hospitals
  4. 5.1.3 Homecare
  5. 5.1.4 Others
  6. 5.2 Global STD Tests Sales Value by Application
  7. 5.2.1 Global STD Tests Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global STD Tests Sales Value by Application (2021-2032)
  9. 5.2.3 Global STD Tests Sales Value Share by Application (2021-2032)
6 STD Tests Regional Value Analysis
  1. 6.1 Global STD Tests Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global STD Tests Sales Value by Region (2021-2032)
  3. 6.2.1 Global STD Tests Sales Value by Region: 2021-2026
  4. 6.2.2 Global STD Tests Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America STD Tests Sales Value (2021-2032)
  7. 6.3.2 North America STD Tests Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe STD Tests Sales Value (2021-2032)
  10. 6.4.2 Europe STD Tests Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific STD Tests Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific STD Tests Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America STD Tests Sales Value (2021-2032)
  16. 6.6.2 South America STD Tests Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa STD Tests Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa STD Tests Sales Value Share by Country, 2025 VS 2032
7 STD Tests Country-level Value Analysis
  1. 7.1 Global STD Tests Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global STD Tests Sales Value by Country (2021-2032)
  3. 7.2.1 Global STD Tests Sales Value by Country (2021-2026)
  4. 7.2.2 Global STD Tests Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA STD Tests Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA STD Tests Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA STD Tests Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada STD Tests Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada STD Tests Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada STD Tests Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico STD Tests Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico STD Tests Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico STD Tests Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany STD Tests Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany STD Tests Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany STD Tests Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France STD Tests Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France STD Tests Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France STD Tests Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. STD Tests Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. STD Tests Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. STD Tests Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy STD Tests Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy STD Tests Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy STD Tests Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain STD Tests Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain STD Tests Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain STD Tests Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia STD Tests Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia STD Tests Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia STD Tests Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands STD Tests Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands STD Tests Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands STD Tests Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries STD Tests Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries STD Tests Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries STD Tests Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China STD Tests Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China STD Tests Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China STD Tests Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan STD Tests Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan STD Tests Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan STD Tests Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea STD Tests Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea STD Tests Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea STD Tests Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India STD Tests Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India STD Tests Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India STD Tests Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia STD Tests Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia STD Tests Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia STD Tests Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia STD Tests Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia STD Tests Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia STD Tests Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil STD Tests Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil STD Tests Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil STD Tests Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina STD Tests Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina STD Tests Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina STD Tests Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile STD Tests Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile STD Tests Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile STD Tests Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia STD Tests Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia STD Tests Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia STD Tests Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru STD Tests Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru STD Tests Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru STD Tests Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia STD Tests Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia STD Tests Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia STD Tests Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel STD Tests Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel STD Tests Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel STD Tests Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE STD Tests Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE STD Tests Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE STD Tests Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey STD Tests Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey STD Tests Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey STD Tests Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran STD Tests Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran STD Tests Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran STD Tests Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt STD Tests Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt STD Tests Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt STD Tests Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Orasure
  2. 8.1.1 Orasure Company Information
  3. 8.1.2 Orasure Business Overview
  4. 8.1.3 Orasure STD Tests Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Orasure STD Tests Product Portfolio
  6. 8.1.5 Orasure Recent Developments
  7. 8.2 Hologic Inc.
  8. 8.2.1 Hologic Inc. Company Information
  9. 8.2.2 Hologic Inc. Business Overview
  10. 8.2.3 Hologic Inc. STD Tests Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Hologic Inc. STD Tests Product Portfolio
  12. 8.2.5 Hologic Inc. Recent Developments
  13. 8.3 F. Hoffmann-La Roche
  14. 8.3.1 F. Hoffmann-La Roche Company Information
  15. 8.3.2 F. Hoffmann-La Roche Business Overview
  16. 8.3.3 F. Hoffmann-La Roche STD Tests Revenue and Gross Margin (2021-2026)
  17. 8.3.4 F. Hoffmann-La Roche STD Tests Product Portfolio
  18. 8.3.5 F. Hoffmann-La Roche Recent Developments
  19. 8.4 DiaSorin
  20. 8.4.1 DiaSorin Company Information
  21. 8.4.2 DiaSorin Business Overview
  22. 8.4.3 DiaSorin STD Tests Revenue and Gross Margin (2021-2026)
  23. 8.4.4 DiaSorin STD Tests Product Portfolio
  24. 8.4.5 DiaSorin Recent Developments
  25. 8.5 Danaher Corporation
  26. 8.5.1 Danaher Corporation Company Information
  27. 8.5.2 Danaher Corporation Business Overview
  28. 8.5.3 Danaher Corporation STD Tests Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Danaher Corporation STD Tests Product Portfolio
  30. 8.5.5 Danaher Corporation Recent Developments
  31. 8.6 Cepheid Inc.
  32. 8.6.1 Cepheid Inc. Company Information
  33. 8.6.2 Cepheid Inc. Business Overview
  34. 8.6.3 Cepheid Inc. STD Tests Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Cepheid Inc. STD Tests Product Portfolio
  36. 8.6.5 Cepheid Inc. Recent Developments
  37. 8.7 Bio-Rad Laboratories
  38. 8.7.1 Bio-Rad Laboratories Company Information
  39. 8.7.2 Bio-Rad Laboratories Business Overview
  40. 8.7.3 Bio-Rad Laboratories STD Tests Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Bio-Rad Laboratories STD Tests Product Portfolio
  42. 8.7.5 Bio-Rad Laboratories Recent Developments
  43. 8.8 BioMerieux
  44. 8.8.1 BioMerieux Company Information
  45. 8.8.2 BioMerieux Business Overview
  46. 8.8.3 BioMerieux STD Tests Revenue and Gross Margin (2021-2026)
  47. 8.8.4 BioMerieux STD Tests Product Portfolio
  48. 8.8.5 BioMerieux Recent Developments
  49. 8.9 Becton Dickinson and Company
  50. 8.9.1 Becton Dickinson and Company Company Information
  51. 8.9.2 Becton Dickinson and Company Business Overview
  52. 8.9.3 Becton Dickinson and Company STD Tests Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Becton Dickinson and Company STD Tests Product Portfolio
  54. 8.9.5 Becton Dickinson and Company Recent Developments
  55. 8.10 Alere Inc.
  56. 8.10.1 Alere Inc. Company Information
  57. 8.10.2 Alere Inc. Business Overview
  58. 8.10.3 Alere Inc. STD Tests Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Alere Inc. STD Tests Product Portfolio
  60. 8.10.5 Alere Inc. Recent Developments
  61. 8.11 Affymetrix
  62. 8.11.1 Affymetrix Company Information
  63. 8.11.2 Affymetrix Business Overview
  64. 8.11.3 Affymetrix STD Tests Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Affymetrix STD Tests Product Portfolio
  66. 8.11.5 Affymetrix Recent Developments
  67. 8.12 Abbott Laboratories
  68. 8.12.1 Abbott Laboratories Company Information
  69. 8.12.2 Abbott Laboratories Business Overview
  70. 8.12.3 Abbott Laboratories STD Tests Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Abbott Laboratories STD Tests Product Portfolio
  72. 8.12.5 Abbott Laboratories Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst